Cargando…
Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group
New cases of the novel coronavirus disease 2019 (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continue to rise worldwide following the declaration of a pandemic by the World Health Organization (WHO). The current pandemic has completely altered the workflow...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Medicina / USP
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297526/ https://www.ncbi.nlm.nih.gov/pubmed/32578829 http://dx.doi.org/10.6061/clinics/2020/e2060 |
_version_ | 1783547024590766080 |
---|---|
author | Baldotto, Clarissa Gelatti, Ana Accioly, Arthur Mathias, Clarissa Mascarenhas, Eldsamira Carvalho, Heloisa Faroni, Lilian Araújo, Luiz Henrique Zukin, Mauro Gadia, Rafael Terra, Ricardo Mingarini Haddad, Rui de Lima, Vladmir Cordeiro de Castro-Júnior, Gilberto |
author_facet | Baldotto, Clarissa Gelatti, Ana Accioly, Arthur Mathias, Clarissa Mascarenhas, Eldsamira Carvalho, Heloisa Faroni, Lilian Araújo, Luiz Henrique Zukin, Mauro Gadia, Rafael Terra, Ricardo Mingarini Haddad, Rui de Lima, Vladmir Cordeiro de Castro-Júnior, Gilberto |
author_sort | Baldotto, Clarissa |
collection | PubMed |
description | New cases of the novel coronavirus disease 2019 (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continue to rise worldwide following the declaration of a pandemic by the World Health Organization (WHO). The current pandemic has completely altered the workflow of health services worldwide. However, even during this critical period, patients with other diseases, like cancer, need to be properly treated. A few reports have shown that mortality due to SARS-CoV-2 is higher in elderly patients and those with other active comorbidities, including cancer. Patients with lung cancer are at risk of pulmonary complications from COVID-19, and as such, the risk/benefit ratio of local and systemic anticancer treatment has to be considered. For each patient, several factors, including age, comorbidities, and immunosuppression, as well as the number of hospital visits for treatment, can influence this risk. The number of cases is rising exponentially in Brazil, and it is important to consider the local characteristics when approaching the pandemic. In this regard, the Brazilian Thoracic Oncology Group has developed recommendations to guide decisions in lung cancer treatment during the SARS-CoV-2 pandemic. Due to the scarcity of relevant data, discussions based on disease stage, evaluation of surgical treatment, radiotherapy techniques, systemic therapy, follow-up, and supportive care were carried out, and specific suggestions issued. All recommendations seek to reduce contagion risk by decreasing the number of medical visits and hospitalization, and in the case of immunosuppression, by adapting treatment schemes when possible. This statement should be adjusted according to the reality of each service, and can be revised as new data become available. |
format | Online Article Text |
id | pubmed-7297526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Faculdade de Medicina / USP |
record_format | MEDLINE/PubMed |
spelling | pubmed-72975262020-06-29 Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group Baldotto, Clarissa Gelatti, Ana Accioly, Arthur Mathias, Clarissa Mascarenhas, Eldsamira Carvalho, Heloisa Faroni, Lilian Araújo, Luiz Henrique Zukin, Mauro Gadia, Rafael Terra, Ricardo Mingarini Haddad, Rui de Lima, Vladmir Cordeiro de Castro-Júnior, Gilberto Clinics (Sao Paulo) Review Article New cases of the novel coronavirus disease 2019 (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continue to rise worldwide following the declaration of a pandemic by the World Health Organization (WHO). The current pandemic has completely altered the workflow of health services worldwide. However, even during this critical period, patients with other diseases, like cancer, need to be properly treated. A few reports have shown that mortality due to SARS-CoV-2 is higher in elderly patients and those with other active comorbidities, including cancer. Patients with lung cancer are at risk of pulmonary complications from COVID-19, and as such, the risk/benefit ratio of local and systemic anticancer treatment has to be considered. For each patient, several factors, including age, comorbidities, and immunosuppression, as well as the number of hospital visits for treatment, can influence this risk. The number of cases is rising exponentially in Brazil, and it is important to consider the local characteristics when approaching the pandemic. In this regard, the Brazilian Thoracic Oncology Group has developed recommendations to guide decisions in lung cancer treatment during the SARS-CoV-2 pandemic. Due to the scarcity of relevant data, discussions based on disease stage, evaluation of surgical treatment, radiotherapy techniques, systemic therapy, follow-up, and supportive care were carried out, and specific suggestions issued. All recommendations seek to reduce contagion risk by decreasing the number of medical visits and hospitalization, and in the case of immunosuppression, by adapting treatment schemes when possible. This statement should be adjusted according to the reality of each service, and can be revised as new data become available. Faculdade de Medicina / USP 2020-06-16 2020 /pmc/articles/PMC7297526/ /pubmed/32578829 http://dx.doi.org/10.6061/clinics/2020/e2060 Text en Copyright © 2020 CLINICS http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited. |
spellingShingle | Review Article Baldotto, Clarissa Gelatti, Ana Accioly, Arthur Mathias, Clarissa Mascarenhas, Eldsamira Carvalho, Heloisa Faroni, Lilian Araújo, Luiz Henrique Zukin, Mauro Gadia, Rafael Terra, Ricardo Mingarini Haddad, Rui de Lima, Vladmir Cordeiro de Castro-Júnior, Gilberto Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group |
title | Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group |
title_full | Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group |
title_fullStr | Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group |
title_full_unstemmed | Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group |
title_short | Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group |
title_sort | lung cancer and the covid-19 pandemic: recommendations from the brazilian thoracic oncology group |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297526/ https://www.ncbi.nlm.nih.gov/pubmed/32578829 http://dx.doi.org/10.6061/clinics/2020/e2060 |
work_keys_str_mv | AT baldottoclarissa lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT gelattiana lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT acciolyarthur lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT mathiasclarissa lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT mascarenhaseldsamira lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT carvalhoheloisa lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT faronililian lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT araujoluizhenrique lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT zukinmauro lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT gadiarafael lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT terraricardomingarini lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT haddadrui lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT delimavladmircordeiro lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup AT decastrojuniorgilberto lungcancerandthecovid19pandemicrecommendationsfromthebrazilianthoraciconcologygroup |